Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
Julphar
Healthtrust
Moodys
Boehringer Ingelheim
Teva
Covington
Dow

Generated: January 20, 2019

DrugPatentWatch Database Preview

Siltuximab - Biologic Drug Details

« Back to Dashboard

Summary for siltuximab
Tradenames:1
Patents:9
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for siltuximab
Mechanism of ActionInterleukin-6 Antagonists

US Patents for siltuximab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up CureVac AG (Tubingen, DE) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up biOasis Technologies, Inc. (Richmond, CA) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Sign Up CureVac AG (Tubingen, DE) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for siltuximab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1562968/01 Switzerland ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: SWISSMEDIC 65183 17.12.2014
14/048 Ireland ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
543 Luxembourg ➤ Sign Up PRODUCT NAME: SILTUXIMAB
0687 Netherlands ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140527
2014 00047 Denmark ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928/001-002 20140522
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Deloitte
Fish and Richardson
Medtronic
Baxter
Argus Health
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.